Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202.

Yan DH, Wen Y, Spohn B, Choubey D, Gutterman JU, Hung MC.

Oncogene. 1999 Jan 21;18(3):807-11.

2.

Prostate-specific antitumor activity by probasin promoter-directed p202 expression.

Wen Y, Giri D, Yan DH, Spohn B, Zinner RG, Xia W, Thompson TC, Matusik RJ, Hung MC.

Mol Carcinog. 2003 Jul;37(3):130-7.

PMID:
12884364
3.
4.

p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models.

Wen Y, Yan DH, Wang B, Spohn B, Ding Y, Shao R, Zou Y, Xie K, Hung MC.

Cancer Res. 2001 Oct 1;61(19):7142-7.

5.

Binding of an interferon-inducible protein (p202) to the retinoblastoma protein.

Choubey D, Lengyel P.

J Biol Chem. 1995 Mar 17;270(11):6134-40.

6.

P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells.

Yan DH, Abramian A, Li Z, Ding Y, Wen Y, Liu TJ, Hunt K.

Biochem Biophys Res Commun. 2003 Mar 28;303(1):219-22.

PMID:
12646190
7.
8.

p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein.

Xin H, D'Souza S, Fang L, Lengyel P, Choubey D.

Oncogene. 2001 Oct 18;20(47):6828-39.

9.

The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain.

Choubey D, Gutterman JU.

Biochem Biophys Res Commun. 1996 Apr 16;221(2):396-401.

PMID:
8619867
10.

Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.

Nagano K, Masters JR, Akpan A, Yang A, Corless S, Wood C, Hastie C, Zvelebil M, Cramer R, Naaby-Hansen S.

Oncogene. 2004 Mar 4;23(9):1693-703.

PMID:
14647428
11.

Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression.

Lembo D, Angeretti A, Benefazio S, Hertel L, Gariglio M, Novelli F, Landolfo S.

J Biol Regul Homeost Agents. 1995 Apr-Jun;9(2):42-6.

PMID:
9127631
12.

Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.

Xin H, Curry J, Johnstone RW, Nickoloff BJ, Choubey D.

Oncogene. 2003 Jul 31;22(31):4831-40.

PMID:
12894224
13.
14.

Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha.

Geng Y, Choubey D.

J Biol Regul Homeost Agents. 2000 Oct-Dec;14(4):263-8. Review.

PMID:
11215814
15.

p202 levels are negatively regulated by serum growth factors.

Geng Y, D'Souza S, Xin H, Walter S, Choubey D.

Cell Growth Differ. 2000 Sep;11(9):475-83.

16.
17.

p202 prevents apoptosis in murine AKR-2B fibroblasts.

Koul D, Lapushin R, Xu HJ, Mills GB, Gutterman JU, Choubey D.

Biochem Biophys Res Commun. 1998 Jun 18;247(2):379-82.

PMID:
9642135
18.

A novel human cancer culture model for the study of prostate cancer.

Yasunaga Y, Nakamura K, Ko D, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Rhim JS.

Oncogene. 2001 Nov 29;20(55):8036-41.

19.

CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.

Fraser MM, Watson PM, Fraig MM, Kelley JR, Nelson PS, Boylan AM, Cole DJ, Watson DK.

Cancer Res. 2005 Jul 15;65(14):6228-36.

20.

Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines.

Mestayer C, Blanchère M, Jaubert F, Dufour B, Mowszowicz I.

Prostate. 2003 Aug 1;56(3):192-200.

PMID:
12772188
Items per page

Supplemental Content

Write to the Help Desk